the fda is keeping a bold - letter warning on pfizer 's anti-smoking drug chantix about suicidal behavior and other psychiatric side effects , after reviewing company findings suggesting the drug does not increase those problems
the twice - a - day tablet has carried the fda 's strongest warning label since 2009 , following reports of suicidal tendencies and violent or bizarre behavior among some patients
the fda on monday outlined several updates to chantix 's labeling , including a new warning about its potential interaction with alcohol
some patients have reported unusual or aggressive behavior when drinking while on chantix
caution : anti-smoking drug chantix has carried the fda 's strongest warning label since 2009 , following reports of suicidal tendencies and violent or bizarre behavior among some patients ' the fda ( fda ) is warning that the prescription smoking cessation medicine chantix ( varenicline ) can change the way people react to alcohol , ' the agency said
warning : the fda on monday outlined several updates to chantix 's labeling , including a new warning about its potential interaction with alcohol
some patients have reported unusual or aggressive behavior when drinking while on chantix the agency 's update follows the recommendation of a panel of outside experts , who voted last october to keep the boxed warning on the drug until it can be reevaluated based on new information
new york - based pfizer is expected to complete a larger study of chantix 's psychiatric side effects in late 2015